Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2375

1.

Novel prospects of statins as therapeutic agents in cancer.

Pisanti S, Picardi P, Ciaglia E, D'Alessandro A, Bifulco M.

Pharmacol Res. 2014 Jul 4. pii: S1043-6618(14)00105-4. doi: 10.1016/j.phrs.2014.06.013. [Epub ahead of print] Review.

PMID:
25009097
[PubMed - as supplied by publisher]
2.

Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature.

Wu JW, Boudreau DM, Park Y, Simonds NI, Freedman AN.

Expert Opin Drug Saf. 2014 Jul 5:1-29. [Epub ahead of print]

PMID:
24999107
[PubMed - as supplied by publisher]
3.

Resistance and intolerance to statins.

Reiner Z.

Nutr Metab Cardiovasc Dis. 2014 Jun 6. pii: S0939-4753(14)00173-2. doi: 10.1016/j.numecd.2014.05.009. [Epub ahead of print] Review.

PMID:
24996502
[PubMed - as supplied by publisher]
4.

Immediate Utility of Two Approved Agents to Target both the Metabolic Mevalonate Pathway and its Restorative Feedback loop.

Pandyra A, Mullen PJ, Kalkat M, Yu R, Pong JT, Li Z, Trudel S, Lang KS, Minden MD, Schimmer AD, Penn LZ.

Cancer Res. 2014 Jul 3. pii: canres.0130.2014. [Epub ahead of print]

PMID:
24994712
[PubMed - as supplied by publisher]
5.

Induction of cholesterol biosynthesis by archazolid B in T24 bladder cancer cells.

Hamm R, Chen YR, Seo EJ, Zeino M, Wu CF, Müller R, Yang NS, Efferth T.

Biochem Pharmacol. 2014 Jun 26. pii: S0006-2952(14)00361-X. doi: 10.1016/j.bcp.2014.06.018. [Epub ahead of print]

PMID:
24976507
[PubMed - as supplied by publisher]
6.

Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: Intermediacy of nitric oxide and antioxidant defence mechanisms.

Kanugula AK, Gollavilli PN, Vasamsetti SB, Karnewar S, Gopoju R, Ummanni R, Kotamraju S.

FEBS J. 2014 Jun 25. doi: 10.1111/febs.12893. [Epub ahead of print]

PMID:
24964743
[PubMed - as supplied by publisher]
7.

Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer.

Lee SJ, Lee I, Lee J, Park C, Kang WK.

Br J Cancer. 2014 Jun 19. doi: 10.1038/bjc.2014.283. [Epub ahead of print]

PMID:
24945998
[PubMed - as supplied by publisher]
8.

Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study.

Livingstone E, Hollestein LM, van Herk-Sukel MP, van de Poll-Franse L, Joosse A, Schilling B, Nijsten T, Schadendorf D, de Vries E.

Cancer Med. 2014 Jun 17. doi: 10.1002/cam4.285. [Epub ahead of print]

PMID:
24935402
[PubMed - as supplied by publisher]
9.

203 Hypoxia-inducible Factor-1 Regulates Matrix Metalloproteinase-14 Expression: Underlying Effects of Hypoxia and Statins.

Moore AD, Hodgkinson C, Lapenna A, Zhang F, Witkowska K, Liang Ng F, Headland SE, Reynolds L, Lees D, Lechertier T, Milsom A, Hodivala-Dilke K, Ye S.

Heart. 2014 Jun;100 Suppl 3:A111-2. doi: 10.1136/heartjnl-2014-306118.203.

PMID:
24922779
[PubMed - in process]
10.

Mortality in Prostate Cancer and Use of Statins.

Tural D, Yuce D, Kilickap S.

J Clin Oncol. 2014 Jun 9. pii: JCO.2013.54.3264. [Epub ahead of print] No abstract available.

PMID:
24912890
[PubMed - as supplied by publisher]
11.

Abnormal Splicing of NEDD4 in Myotonic Dystrophy Type 2: A Possible Link to Statin Adverse Reactions.

Screen M, Jonson PH, Raheem O, Palmio J, Laaksonen R, Lehtimäki T, Sirito M, Krahe R, Hackman P, Udd B.

Am J Pathol. 2014 Jun 5. pii: S0002-9440(14)00271-5. doi: 10.1016/j.ajpath.2014.04.013. [Epub ahead of print]

PMID:
24907641
[PubMed - as supplied by publisher]
12.

Fluvastatin inhibits growth and alters the malignant phenotype of the C6 glioma cell line.

Sławińska-Brych A, Zdzisińska B, Kandefer-Szerszeń M.

Pharmacol Rep. 2014 Feb;66(1):121-9. doi: 10.1016/j.pharep.2014.01.002. Epub 2014 Feb 1.

PMID:
24905317
[PubMed - in process]
13.

Do statins increase and Mediterranean diet decrease the risk of breast cancer?

de Lorgeril M, Salen P.

BMC Med. 2014 Jun 5;12(1):94. doi: 10.1186/1741-7015-12-94.

PMID:
24903828
[PubMed - in process]
Free Article
14.

Lovastatin inhibited the growth of gastric cancer cells.

Cheng-Qian Y, Xin-Jing W, Wei-Xinbing, Zhuang-Lei G, Hong-Peng Z, Songde X, Pei-Lin W.

Hepatogastroenterology. 2014 Jan-Feb;61(129):1-4.

PMID:
24895782
[PubMed - indexed for MEDLINE]
15.

Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes.

Kong AP, Yang X, So WY, Luk A, Ma RC, Ozaki R, Cheung KK, Lee HM, Yu L, Xu G, Chow CC, Chan JC.

BMC Med. 2014 May 13;12(1):76. doi: 10.1186/1741-7015-12-76.

PMID:
24886453
[PubMed - in process]
Free PMC Article
16.

Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer.

Schointuch MN, Gilliam TP, Stine JE, Han X, Zhou C, Gehrig PA, Kim K, Bae-Jump VL.

Gynecol Oncol. 2014 May 28. pii: S0090-8258(14)00975-5. doi: 10.1016/j.ygyno.2014.05.015. [Epub ahead of print]

PMID:
24880141
[PubMed - as supplied by publisher]
17.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 May 31;5:CD007784. doi: 10.1002/14651858.CD007784.pub2.

PMID:
24880031
[PubMed - in process]
18.

Unconventional approaches to the prevention of cancer associated thrombosis.

Zwicker JI.

Thromb Res. 2014 May;133 Suppl 2:S44-8. doi: 10.1016/S0049-3848(14)50008-4.

PMID:
24862145
[PubMed - in process]
19.

Evaluation of Organic Anion Transporting Polypeptide 1B1 and 1B3 Humanized Mice as a Translational Model to Study the Pharmacokinetics of Statins.

Salphati L, Chu X, Chen L, Prasad B, Dallas S, Evers R, Mamaril-Fishman D, Geier EG, Kehler J, Kunta J, Mezler M, Laplanche L, Pang J, Rode A, Soars MG, Unadkat JD, van Waterschoot RA, Yabut J, Schinkel AH, Scheer N.

Drug Metab Dispos. 2014 Aug;42(8):1301-13. doi: 10.1124/dmd.114.057976. Epub 2014 May 22.

PMID:
24855184
[PubMed - in process]
Free Article
20.

Blind Snipers: Relevant Off Target Effects of Non-Chemotherapeutic Agents in Oncology. Review of the Literature.

Prochilo T, Di Biasi B, Aroldi F, Bertocchi P, Sabatini T, Meriggi F, Zaniboni A.

Rev Recent Clin Trials. 2014 May 22. [Epub ahead of print]

PMID:
24854040
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk